Ian Dunn to Meningeal Neoplasms
This is a "connection" page, showing publications Ian Dunn has written about Meningeal Neoplasms.
Connection Strength
8.115
-
Open Surgical Approaches for Meningiomas. Neurosurg Clin N Am. 2023 Jul; 34(3):381-391.
Score: 0.798
-
High-grade meningiomas: biology and implications. Neurosurg Focus. 2018 04; 44(4):E2.
Score: 0.564
-
Osteoglycin promotes meningioma development through downregulation of NF2 and activation of mTOR signaling. Cell Commun Signal. 2017 09 18; 15(1):34.
Score: 0.543
-
Current and emerging principles in surgery for meningioma. Chin Clin Oncol. 2017 Jul; 6(Suppl 1):S7.
Score: 0.535
-
Genomic profile of human meningioma cell lines. PLoS One. 2017; 12(5):e0178322.
Score: 0.532
-
Genomic and Epigenomic Landscape in Meningioma. Neurosurg Clin N Am. 2016 Apr; 27(2):167-79.
Score: 0.491
-
Genomic landscape of intracranial meningiomas. J Neurosurg. 2016 09; 125(3):525-35.
Score: 0.484
-
Preclinical Models of Meningioma. Adv Exp Med Biol. 2023; 1416:199-211.
Score: 0.196
-
Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations. J Clin Oncol. 2023 01 20; 41(3):618-628.
Score: 0.193
-
A molecularly integrated grade for meningioma. Neuro Oncol. 2022 05 04; 24(5):796-808.
Score: 0.187
-
Posterior Clinoid Meningioma-A Formidable Entity: 2-Dimensional Operative Video. Oper Neurosurg (Hagerstown). 2022 05 01; 22(5):e216.
Score: 0.187
-
Biology and Treatment of Meningiomas: A Reappraisal. Hematol Oncol Clin North Am. 2022 02; 36(1):133-146.
Score: 0.184
-
Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results. Neuro Oncol. 2022 01 05; 24(1):101-113.
Score: 0.183
-
Is Falcine Meningioma a Diffuse Disease of the Falx? Case Series and Analysis of a "Grade Zero" Resection. Neurosurgery. 2020 10 15; 87(5):900-909.
Score: 0.168
-
Brachytherapy with surgical resection as salvage treatment for recurrent high-grade meningiomas: a matched cohort study. J Neurooncol. 2020 Jan; 146(1):111-120.
Score: 0.158
-
Atypical Histopathological Features and the Risk of Treatment Failure in Nonmalignant Meningiomas: A Multi-Institutional Analysis. World Neurosurg. 2020 Jan; 133:e804-e812.
Score: 0.157
-
Advances in multidisciplinary therapy for meningiomas. Neuro Oncol. 2019 01 14; 21(Suppl 1):i18-i31.
Score: 0.149
-
Molecular and translational advances in meningiomas. Neuro Oncol. 2019 01 14; 21(Suppl 1):i4-i17.
Score: 0.149
-
Imaging and diagnostic advances for intracranial meningiomas. Neuro Oncol. 2019 01 14; 21(Suppl 1):i44-i61.
Score: 0.149
-
Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group. Neuro Oncol. 2019 01 01; 21(1):26-36.
Score: 0.149
-
Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma. Cancer Med. 2019 01; 8(1):13-20.
Score: 0.149
-
Medical management of meningioma in the era of precision medicine. Neurosurg Focus. 2018 04; 44(4):E3.
Score: 0.141
-
Radiographic prediction of meningioma grade by semantic and radiomic features. PLoS One. 2017; 12(11):e0187908.
Score: 0.137
-
Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas. Neuro Oncol. 2017 04 01; 19(4):535-545.
Score: 0.132
-
Hybrid Surgery Management of Giant Hypervascular Tumors: Intraoperative Endovascular Embolization with Microsurgical Resection. World Neurosurg. 2017 Jun; 102:157-166.
Score: 0.131
-
Impact of operative length on post-operative complications in meningioma surgery: a NSQIP analysis. J Neurooncol. 2017 01; 131(1):59-67.
Score: 0.128
-
Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma. Neuro Oncol. 2016 05; 18(5):649-55.
Score: 0.121
-
A prognostic cytogenetic scoring system to guide the adjuvant management of patients with atypical meningioma. Neuro Oncol. 2016 Feb; 18(2):269-74.
Score: 0.118
-
Extent of resection and overall survival for patients with atypical and malignant meningioma. Cancer. 2015 Dec 15; 121(24):4376-81.
Score: 0.118
-
ARID1A and TERT promoter mutations in dedifferentiated meningioma. Cancer Genet. 2015 Jun; 208(6):345-50.
Score: 0.114
-
Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma. Oncotarget. 2015 Mar 10; 6(7):4704-16.
Score: 0.114
-
Angiomatous meningiomas have a distinct genetic profile with multiple chromosomal polysomies including polysomy of chromosome 5. Oncotarget. 2014 Nov 15; 5(21):10596-606.
Score: 0.112
-
Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningioma. Neuro Oncol. 2014 Nov; 16(11):1547-53.
Score: 0.108
-
True petroclival meningiomas: results of surgical management. J Neurosurg. 2014 Jan; 120(1):40-51.
Score: 0.104
-
Meningiomas involving the optic canal: pattern of involvement and implications for surgical technique. Neurosurg Focus. 2011 May; 30(5):E12.
Score: 0.087
-
Impact of insurance on hospital course and readmission after resection of benign meningioma. J Neurooncol. 2020 Aug; 149(1):131-140.
Score: 0.041
-
Delayed Carotid Pseudoaneurysms from Iatrogenic Clival Meningeal Branches Avulsion: Recognition and Proposed Management. World Neurosurg. 2017 Aug; 104:736-744.
Score: 0.033
-
High incidence of TERT mutation in brain tumor cell lines. Brain Tumor Pathol. 2016 Jul; 33(3):222-7.
Score: 0.031
-
Ambient mass spectrometry for the intraoperative molecular diagnosis of human brain tumors. Proc Natl Acad Sci U S A. 2013 Jan 29; 110(5):1611-6.
Score: 0.025
-
A novel TP53 germline mutation in a family with a history of multiple malignancies: case report and review of the literature. Pediatr Neurosurg. 2008; 44(6):501-8.
Score: 0.019